Loading...
Orion Nutraceuticals Inc.
ORI.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.40
CA$0.00(0.00%)

Over the past four quarters, Orion Nutraceuticals Inc. demonstrated steady revenue growth, increasing from $0.00 in Q3 2023 to $0.00 in Q2 2024. Operating income reached $0.00 in Q2 2024, maintaining a consistent N/A margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$51339.00, reflecting operational efficiency. Net income dropped to -$50919.00, with EPS at $0.00. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan